North Bay Business Journal

  • Medical-device maker Sanovas picks Sausalito for production

    January 30th, 2012

    SAUSALITO — Sanovas Inc. plans to expand its corporate headquarters in Marin County’s southernmost city to include a manufacturing operation for early production of key components used in its microsurgical devices, used in diagnosing and treating cancer and other chronic diseases.

  • Sanovas plans Sausalito expansion for production

    January 24th, 2012

    SAUSALITO — Sanovas Inc. today announced it will expand its corporate headquarters in Marin County’s southernmost city and start local assembly of key components for its microsurgical devices, used in diagnosing and treating cancer and other chronic diseases. The startup plans to hire 20 locally this year.

  • Claret Medical raises $3 million, gets EU product approval

    October 31st, 2011

    SANTA ROSA — Claret Medical, Inc., a recently formed Santa Rosa-based developer of methods designed to protect against brain embolism during vascular intervention and surgery, received European Union approval today for its Montage System. It’s the second product approval this year. Claret has raised most of a $3.5 million round of private equity financing opened in late summer.

  • Sapheon vein closure system gets EU approval

    September 22nd, 2011

    SANTA ROSA — Sapheon Inc., a medical device maker that develops treatments for vascular disease, announced that it has received approval in Europe for its approach to the treatment of varicose veins caused by venous reflux disease.

  • Oculus increases revenue to $2.9 million

    August 5th, 2011

    PETALUMA — Oculus Innovative Sciences (Nasdaq:OCLS) said it has increased its total revenue to $2.9 million for the first quarter of fiscal year 2012, ended June 30, compared to $2.3 million in the first quarter of fiscal year 2011.

  • TriVascular takes Ovation across Europe

    April 18th, 2011

    SANTA ROSA — TriVascular, maker of stent grafts for endovascular aneurysm repair (EVAR), is marching across Europe with its first product. The Ovation stent graft system was approved for sale overseas last year.

  • TriVascular enrolls in pivotal study for U.S. market

    March 24th, 2011

    SANTA ROSA — TriVascular Inc. announced enrollment is complete for the U.S. pivotal study of its Ovation abdominal stent graft system.

  • Memorial implants MRI-safe Medtronic pacemaker

    March 21st, 2011

    SANTA ROSA — Santa Rosa Memorial Hospital last week implanted an MRI-safe pacemaker into a patient, making it the first hospital north of the Golden Gate Bridge to do so, according to the hospital and the medical device maker.

  • Another $22 million for Sonoma Orthopedic

    February 14th, 2011

    SANTA ROSA — Sonoma Orthopedic Products today announced the company closed a series D financing round totaling $22 million that will be used to fund salesforce expansion, new products, clinical trials and the acquisition of certain key assets of NovaLign Orthopaedics Inc.

  • Sonoma Orthopedic acquires ‘key assets’ from NovaLign

    February 11th, 2011

    SANTA ROSA — Sonoma Orthopedic Products, Inc. announced today that it acquired “certain key assets” from Memphis-based NovaLign Orthopedics, Inc.

  • Medical startup targets vein disease

    December 6th, 2010

    SANTA ROSA – Human trials begin this week on a device that could change the way a chronic, universal disease is treated.

  • BioMarin, Buck Institute, TriVascular in growth mode

    September 6th, 2010

    NOVATO and SANTA ROSA — BioMarin Pharmaceuticals, the Buck Institute for Age Research and TriVascular are expanding research, products and staff. Each has innovative products either on the market or under development, with a healthy cushion of capital for future growth.

  • TriVascular in first U.S. clinical trial; will add 100 jobs

    May 5th, 2010

    SANTA ROSA — TriVascular announced today the first U.S. clinical study of its abdominal stent graft, a device that promises to significantly increase the pool of candidates for minimally invasive treatment of aortic aneurisms.

  • TriVascular trials progress in Europe

    March 29th, 2010

    SANTA ROSA — TriVascular’s abdominal stent graft is showing solid results in European clinical trials, well on its way to holding a leading position in a predicted $2 billion global market.

  • Medical device startup Osseon gets traction

    February 8th, 2010

    SANTA ROSA – Medical device startup Osseon Therapeutics has reached break-even in three short years, and its bone cement delivery system is in high demand among physicians and surgery centers, said a company spokesman.

Site Index

Industry News
Events
Mobile

Tags